Unrecognized anemia in patients with diabetes - A cross-sectional survey

被引:251
作者
Thomas, MC
MacIsaac, R
Tsalamandris, C
Power, D
Jerums, G
机构
[1] Austin & Repatriat Med Ctr, Dept Med, Heidelberg, Vic, Australia
[2] Austin & Repatriat Med Ctr, Dept Endocrinol, Heidelberg, Vic, Australia
[3] Austin & Repatriat Med Ctr, Dept Nephrol, Heidelberg, Vic, Australia
关键词
D O I
10.2337/diacare.26.4.1164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Anemia is common in diabetes, potentially contributing to the pathogenesis of diabetes complications. This study aims to establish the prevalence and independent predictors of anemia in a cross-sectional survey of 820 patients with diabetes in long-term follow-up in a single clinic. RESEARCH DESIGN AND METHODS - A full blood count was obtained in addition to routine blood and urine test results for all patients over a 2-year period to encompass all patterns of review. Predictors of the most recent Hb concentration and anemia were identified using multiple and logistic regression analysis. RESULTS - A total of 190 patients (23%) had unrecognized anemia,(Hb < 12 g/dl for women and <13 g/dl for men). This prevalence is two to three times higher than for patients with comparable renal impairment and iron stores in the general population. Independent predictors for Hb were transferrin saturation, glomerular filtration rate (GFR), sex, albumin excretion rate, and HbA(1c) level (all P < 0.0001). Microalbuminuric patients were >2 times (odds ratio [OR] 2.3) and macroalbuminuric patients >10 times (OR 10.1) as likely to have anemia than normoalbuminuric patients with preserved renal function (GFR >80 ml/min). CONCLUSIONS - Anemia is a common accompaniment to diabetes, particularly in those with albuminuria or reduced renal function. Additional factors present in diabetes may contribute to the development of increased risk for anemia in patients with diabetes.
引用
收藏
页码:1164 / 1169
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 2001, Am J Kidney Dis, V37, pS182
[2]   Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994) [J].
Astor, BC ;
Muntner, P ;
Levin, A ;
Eustace, JA ;
Coresh, J .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) :1401-1408
[3]   Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure [J].
Bosman, DR ;
Osborne, CA ;
Marsden, JT ;
Macdougall, IC ;
Gardner, WN ;
Watkins, PJ .
DIABETIC MEDICINE, 2002, 19 (01) :65-69
[4]   Anemia with erythropoietin deficiency occurs early in diabetic nephropathy [J].
Bosman, DR ;
Winkler, AS ;
Marsden, JT ;
Macdougall, IC ;
Watkins, PJ .
DIABETES CARE, 2001, 24 (03) :495-499
[5]  
Cody J, 2001, COCHRANE DB SYST REV, V4
[6]   Soluble transferrin receptor level - A new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes [J].
De Block, CEM ;
Van Campenhout, CM ;
De Leeuw, IH ;
Keenoy, BMY ;
Martin, M ;
Van Hoof, V ;
Van Gaal, LF .
DIABETES CARE, 2000, 23 (09) :1384-1388
[7]   How should we manage anaemia in patients with diabetes? [J].
Dikow, R ;
Schwenger, V ;
Schömig, M ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :67-72
[8]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[9]   Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors [J].
Erturk, S ;
Ates, K ;
Duman, N ;
Karatan, O ;
Erbay, B ;
Ertug, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) :396-397
[10]   Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin [J].
Hayashi, K ;
Hasegawa, K ;
Kobayashi, S .
KIDNEY INTERNATIONAL, 2001, 60 (05) :1910-1916